Announcements Categories Investors Announcements Reports Corporate Governance Share Registry Investor Enquiries Our Board Our Principal Advisors Our Technology Presentations About Us Company Background Intellectual Property January 25, 2023 Genetics Signatures (ASX:GSS)- Notification of cessation of securities ASX: GSS – Notification of cessation of securities December 9, 2022 Genetics Signatures (ASX:GSS) – Investor Webinar Presentation View Announcement October 29, 2022 Genetic Signatures (ASX:GSS) – Quarterly update and Appendix 4C View Announcement September 29, 2022 Genetics Signatures (ASX:GSS) – 3base® Kit for Antimicrobial Resistance View Announcement September 7, 2022 Genetics Signatures (ASX:GSS) – Investor Presentation View Announcement September 1, 2022 Genetics Signatures (ASX:GSS) – Appendix 4E – Preliminary Final Report View Announcement July 27, 2022 Genetics Signatures (ASX:GSS) – Quarterly update and Appendix 4C View Announcement July 26, 2022 Genetic Signatures (ASX:GSS) – Clinical Trial Recruitment Completed for US Enteric Kit View Announcement May 13, 2022 Genetic Signatures (ASX:GSS) – Appointment of Non-Executive Director, Caroline Waldron View Announcement March 31, 2022 Quarterly Activities Report and Appendix 4C View Announcement « Previous 1 … 4 5 6 7 8 … 23 Next » View GSS ASX Announcements on asx.com.au
